• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Skin Microbiota
      • Anti-oxidant
        • Oxidative stress
        • Lipid peroxidation
        • Glutathione Stock
      • Wound Healing
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter

IA

HCS, HCA & Biology

How automation will transform the lab of the future

Now, life science companies are seeking ways to modernise research environments and build the ‘Lab of The Future’ (LoTF). Given advances made in recent years, it’s natural that technology that can automate lab functions – including Artificial Intelligence (AI) – will play an important role in this modernisation drive. In Read more…

By Grégory MAUBON, 2 years ago
News

Digital workspace and the use of immersive technologies: we share our experiments!

Last friday, our CDO talked at IT for Business meeting about the digital workspace and the use of immersive technologies in the evolution of work. It was a pleasure to share our experiences with famous companies like e.sncf, Axa France, Bouygues Telecom Entreprises or Forrester Research! Even if we are Read more…

By Nathalie MAUBON, 3 years4 months ago
HCS, HCA & Biology

Du Deep Learning pour aider au dépistage du cancer du poumon

Deep Learning et Imagerie pour dépister le cancer

By Grégory MAUBON, 4 years4 years ago
HCS, HCA & Biology

The Most Exciting Medical Technologies of 2017 for The Medical Futurist

At HCS Pharma, we work on many of the most exiting medical technologies !

By Grégory MAUBON, 4 years4 years ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • The importance of extracellular matrix in cancers
  • Webinar “Applications for 3D in vitro models with BIOMIMESYS® Adipose Tissue and preview of future BIOMIMESYS® Skin” (April 20 & 22)
  • Lucille joins us to develop hepatocellular models and hiPSCs-derived liver organoids
  • Our next webinar with Molecular Devices : A physiologically-relevant 3D ECM for in vitro oncology research and intelligent high-content imaging of 3D models
  • In silico drug development: a perfect supplement to our in vitro 3D BIOMIMESYS technology
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell CHOPIN congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix forum labo genotoxicity HCA HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro liver meeting Microbiota microenvironment microscopy model Molecular Devices NEUROCELL3D neurotoxicity oncology Parkinson phenotypic screening picture rennes screening skin toxicology
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress